Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 393.25
-2.00 (-0.51%)
Nov 25, 2025, 3:30 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 524.78 billion as of November 25, 2025. Its market cap has increased by 38.89% in one year.
Market Cap
524.78B
Enterprise Value
691.61B
Revenue
164.76B
Ranking
n/a
PE Ratio
100.69
Stock Price
393.25
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 524.78B, an increase of 1,055.57%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 524.78B | 20.02% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | 551.59B | 58.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 930.06B |
| Mankind Pharma | 925.45B |
| Aurobindo Pharma | 700.39B |
| Fortis Healthcare | 695.32B |